What’s New

Over 250 portfolio companies and stakeholders were recently surveyed to assess their satisfaction with JMJ Financial and to solicit their recommendations for improvement.  The survey focused on key areas of our business including communication, customer satisfaction, program specifics, and market competitiveness.  Below are a few… Read more

JMJ Financial’s new Life Sciences Fund offers emerging life sciences companies expanded access to unsecured development capital. With a simple convertible note structure similar to our popular QuickLoans, eligible publicly-traded companies will receive up to $2,000,000 in initial funding, with follow-on funding totaling $4,000,000 or… Read more